Carcinoma, Verrucous
A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)
Subtype terms (1)
More specific conditions that are subtypes of Carcinoma, Verrucous in the MeSH hierarchy.
Drugs by status
Phase 4 trials (2)
Phase 3 trials (7)
Phase 2 trials (29)
- east indian sandalwood oil
- saracatinib
- mk-1775
- sorafenib
- irinotecan
- temsirolimus
- echinacea
- paclitaxel
- lapatinib
- photochlor
- ispinesib
- ixabepilone
- pembrolizumab
- buparlisib
- porfimer
- methylene blue
- cetuximab
- beractant
- dasatinib
- bortezomib
- capecitabine
- vandetanib
- zinc dichloride
- cediranib
- erlotinib
- vaccinium myrtillus
- macleaya cordata
- soybean
- enoxacin
Phase 1 trials (14)
Organizations
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (19)
- Catalysis SL
- University of Pennsylvania
- Case Western Reserve University
- Cornell University
- Harvard University
- Eastern Cooperative Oncology Group
- Temple University
- Ohio State University
- Southwest Oncology Group
- University of Michigan
- University of South Florida
- University of Toronto
- University of Virginia
- University of California, Los Angeles
- University of Chicago
- University of Texas at Houston
- State University of New York, Buffalo
- University of Texas, San Antonio
- National Comprehensive Cancer Network
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (4)